Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer

Date
2018
Author
Woldu, Solomon L.
Milowsky, Matthew I.
Sanli, Oner
Black, Peter
Lotan, Yair
Metadata
Show full item record
Abstract
ObjectivesTo model the cost-effectiveness of a biomarker-based approach to select patients for neoadjuvant chemotherapy (NAC) before radical cystectomy (RC) in muscle-invasive bladder cancer (MIBC).
URI
http://hdl.handle.net/20.500.12627/130837
https://doi.org/10.1111/bju.14220
Collections